Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
favipiravir (5 trials)
Influenza, Human (Phase 3)
Liver Diseases (Phase 1)
Trials (5 total)
Trial APIs (1 total)